New opportunity for developing simple test to measure E2F4 activity in ER+ breast can

[News]

By looking at the expression levels of downstream genes of the regulators in breast cancer, investigators at Dartmouth Hitchcock's Norris Cotton Cancer Center, led by Chao Cheng, PhD, have identified a gene signature in E2F4 that is predictive of estrogen receptor positive (ER+) breast cancer.

More... (http://www.news-medical.net/news/20150108/New-opportunity-for-developing-simple-test-to-measure-E2F4-activity-in-ER2b-breast-cancer-patients.aspx)